234 related articles for article (PubMed ID: 15302515)
1. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
[TBL] [Abstract][Full Text] [Related]
2. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
Sampaio FJ
Int Braz J Urol; 2004; 30(4):349-50. PubMed ID: 15679983
[No Abstract] [Full Text] [Related]
3. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
[TBL] [Abstract][Full Text] [Related]
4. Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome.
Rehman S; Salway F; Stanley JK; Ollier WE; Day P; Bayat A
J Hand Surg Am; 2008 Mar; 33(3):359-72. PubMed ID: 18343292
[TBL] [Abstract][Full Text] [Related]
5. Expression of a novel gene, MafB, in Dupuytren's disease.
Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
[TBL] [Abstract][Full Text] [Related]
6. Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes.
Shih B; Wijeratne D; Armstrong DJ; Lindau T; Day P; Bayat A
J Hand Surg Am; 2009 Jan; 34(1):124-36. PubMed ID: 19121738
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles in the Peyronie's disease plaque.
Magee TR; Qian A; Rajfer J; Sander FC; Levine LA; Gonzalez-Cadavid NF
Urology; 2002 Mar; 59(3):451-7. PubMed ID: 11880101
[TBL] [Abstract][Full Text] [Related]
8. Comparison of apoptotic gene expression profiles between Peyronie's disease plaque and tunica albuginea.
Zorba OU; Sirma S; Ozgon G; Salabas E; Ozbek U; Kadioglu A
Adv Clin Exp Med; 2012; 21(5):607-14. PubMed ID: 23356197
[TBL] [Abstract][Full Text] [Related]
9. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
Johnston P; Chojnowski AJ; Davidson RK; Riley GP; Donell ST; Clark IM
J Hand Surg Am; 2007 Mar; 32(3):343-51. PubMed ID: 17336841
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
Ulrich D; Ulrich F; Piatkowski A; Pallua N
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
[TBL] [Abstract][Full Text] [Related]
11. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.
Vi L; Feng L; Zhu RD; Wu Y; Satish L; Gan BS; O'Gorman DB
Exp Cell Res; 2009 Dec; 315(20):3574-86. PubMed ID: 19619531
[TBL] [Abstract][Full Text] [Related]
12. Wnt expression is not correlated with beta-catenin dysregulation in Dupuytren's Disease.
O'Gorman DB; Wu Y; Seney S; Zhu RD; Gan BS
J Negat Results Biomed; 2006 Aug; 5():13. PubMed ID: 16942611
[TBL] [Abstract][Full Text] [Related]
13. Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie's disease, Dupuytren disease and diabetes.
Gelbard MK; Rosenbloom J
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00195. PubMed ID: 33855203
[TBL] [Abstract][Full Text] [Related]
14. [Gene expression profiles and effects of transforming growth factor-beta1 intervention in Peyronie's disease].
Wang Z; Liu JF; Zhou ZH; Zhang YF; Wang WJ; Zhang P; Selcuk Y; Guiting L; Lin CS
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):182-6. PubMed ID: 15062068
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway.
Ratkaj I; Bujak M; Jurišić D; Baus Lončar M; Bendelja K; Pavelić K; Kraljević Pavelić S
Cell Physiol Biochem; 2012; 30(4):927-42. PubMed ID: 22965824
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease.
Forrester HB; Temple-Smith P; Ham S; de Kretser D; Southwick G; Sprung CN
PLoS One; 2013; 8(3):e59056. PubMed ID: 23554969
[TBL] [Abstract][Full Text] [Related]
17. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.
Satish L; LaFramboise WA; Johnson S; Vi L; Njarlangattil A; Raykha C; Krill-Burger JM; Gallo PH; O'Gorman DB; Gan BS; Baratz ME; Ehrlich GD; Kathju S
BMC Med Genomics; 2012 May; 5():15. PubMed ID: 22559715
[TBL] [Abstract][Full Text] [Related]
18. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
[TBL] [Abstract][Full Text] [Related]
19. Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.
Vi L; Njarlangattil A; Wu Y; Gan BS; O'Gorman DB
BMC Musculoskelet Disord; 2009 Jun; 10():72. PubMed ID: 19545383
[TBL] [Abstract][Full Text] [Related]
20. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.
Satish L; Gallo PH; Baratz ME; Johnson S; Kathju S
BMC Musculoskelet Disord; 2011 May; 12():113. PubMed ID: 21612641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
